Welcome to Bench2Practice
Here, you’ll find credible, data-driven education, tools, and resources to elevate your knowledge of vaccines and help you communicate with your patients.
Scroll to explore all educational content and click on the title of interest to view.
Select Category:
Select Category:
Cardiovascular and Cardiovascular Diseases
Populations at Risk: COVID-19 and Cardiovascular Disease
“Description Primary care physicians and pharmacists have been frontline healthcare providers during the COVID-19 pandemic, delivering immunizations and information about COVID-19 vaccines to their patients. In this series, experts discuss vaccine uptake and provide their best practices for addressing vaccine hesitancy in both adult and pediatric populations. They will address key questions that you and your patients may have regarding vaccine efficacy and safety, bivalent boosters, and common myths about COVID-19.
In this video, experts describe common factors behind parental vaccine hesitancy and provide best practices for effectively communicating the risks of vaccination versus the risks of COVID-19 to concerned parents.
Cardiovascular and Cardiovascular Diseases
Populations at Risk: COVID-19 and Cardiovascular Disease
COVID-19 can worsen cardiovascular disease (CVD), which is why COVID-19 vaccines are especially important for people with underlying CVD. David Strain, professor of Cardiometabolic Health at the University of Exeter Medical School sits down with Dr. Biykem Bozkurt, cardiologist and Senior Dean of the Baylor College of Medicine to discuss how COVID-19 affects the cardiovascular system, and how to speak about the safety and effectiveness of COVID-19 vaccines specifically to people who have heart conditions.
Populations at Risk: COVID-19 and Cerebrovascular Disease
In this program, experts discuss the relationship between COVID-19 and cerebrovascular disease, specifically stroke. They delve into the bidirectional association between the two conditions, shedding light on how COVID-19 impacts stroke patients and how pre-existing cerebrovascular disease can worsen COVID-19 outcomes. They close with a review on how vaccination plays a pivotal role in mitigating these risks.
COVID-19, Heart Injury and Heart Attack
Millions of people in the US suffer from heart attacks every year. In this video, Drs. Biykem Bozkurt and Nicole Bhave discuss the burden how COVID-19 increases the risk of cardiac damage and heart attacks, describe the effectiveness of vaccination against COVID-19 to help protect against heart attacks, and provide CDC recommendations for COVID-19 vaccination.
Populations at Risk Series: COVID-19 and Cardiovascular and Cerebrovascular Disease (1/3)
Cardiovascular complications have been seen with a variety of different viral infections. These complications were seen frequently in patients infected with the SARS-CoV-2 virus. This webinar discusses the relationship between COVID-19 and cardiovascular disease. The goal is to provide each healthcare professional with the tools to be able to discuss COVID-19 risk with the patients with cardiovascular disease and to reduce the risk of severe outcomes.
Populations at Risk Series: COVID-19 and Cardiovascular and Cerebrovascular Disease (2/3)
Cardiovascular complications have been seen with a variety of different viral infections. These complications were seen frequently in patients infected with the SARS-CoV-2 virus. This webinar discusses the relationship between COVID-19 and cardiovascular disease. The goal is to provide each healthcare professional with the tools to be able to discuss COVID-19 risk with the patients with cardiovascular disease and to reduce the risk of severe outcomes.
Populations at Risk Series: COVID-19 and Cardiovascular and Cerebrovascular Disease (3/3)
Cardiovascular complications have been seen with a variety of different viral infections. These complications were seen frequently in patients infected with the SARS-CoV-2 virus. This webinar discusses the relationship between COVID-19 and cardiovascular disease. The goal is to provide each healthcare professional with the tools to be able to discuss COVID-19 risk with the patients with cardiovascular disease and to reduce the risk of severe outcomes.
COVID-19 and COPD
COVID-19 infection can lead to more severe outcomes in patients with COPD. These outcomes can include more acute COVID-19 disease severity, higher likelihood of mortality, ICU admission, and need for ventilation and intubation. It’s important to educate and protect this patient group by informing them of their increased risk factors and how to best manage them, including recommending vaccination and adhering to public health recommendations.
The Importance of Protecting against COVID-19 in patients with Cardiovascular Diseases
This video delves into the critical importance of protecting patients with cardiovascular diseases against COVID-19, highlighting the bidirectional relationship between cardiovascular conditions and COVID-19 severity. It emphasizes. with the help of the dashboard, the increased risk of hospitalizations and mortality in such patients and underscores the role of comorbid conditions like hypertension, obesity, and diabetes in exacerbating these risks.
People with blood vessel and heart conditions can get very sick from COVID-19. Learn how you can protect your patients.
Chronic Diseases
COVID-19 and Chronic Lung Disease
This short video provides an overview of the relationship between COVID-19 and chronic lung disease, including explaining why individuals with this disease are at a heightened risk of COVID-19 infection and hospitalization. The video addresses specific factors contributing to this higher risk, such as higher infection rates, additional immunosuppressive medications and how those with chronic lung disease have been impacted by the ongoing pandemic. Additionally, it delves into COVID-19 prevention and treatment options for individuals with CKD, by offering valuable insights to support HCPs’ understanding of chronic lung disease in navigating the challenges posed by COVID-19.
Populations at Risk: COVID-19 and Chronic Kidney Disease
This 15-minute video provides an overview of the relationship between COVID-19 and chronic kidney disease (CKD). It explains what CKD is and highlights why individuals with CKD are at a heightened risk of COVID-19 infection and hospitalization. The video addresses specific factors contributing to this higher risk, such as higher infection rates, additional immunosuppressive medications, potential exposure during dialysis sessions, and how those with CKD have been impacted by the ongoing pandemic. Additionally, it delves into COVID-19 prevention and treatment options for individuals with CKD, and explores the intersection of acute kidney injury and COVID-19. By offering valuable insights, the video aims to enhance HCPs’ understanding and support individuals with CKD in navigating the challenges posed by COVID-19.
Populations at Risk: COVID-19 and Chronic Liver Disease
In this video, experts discuss the significant impact of COVID-19 on individuals with chronic liver disease and the potential factors that may contribute to this impact. They also review CDC recommendations for COVID-19 vaccination and discuss the data to support the uptake of COVID-19 vaccines in this population.
Populations at Risk Series: COVID-19 and Chronic Disease
People with chronic diseases such as type 2 diabetes, obesity, chronic kidney disease and liver disease are at elevated risk of severe COVID-19 outcomes. Many of these individuals have multiple comorbid conditions which further increase their risk of COVID-related hospitalization and mortality. These patients with these conditions are commonly seen in clinical practice. Many of these individuals are not up to date with current COVID-19 vaccine recommendations. This webinar reviews the impact of COVID-19 in these highly prevalent conditions and what immunizers can do to help lower their risk.
COVID-19 and Diabetes
Diabetes is a chronic health condition characterized by the body’s inability to metabolize glucose properly. It is often poorly managed, leading to microvascular and macrovascular disease. Individuals with diabetes face a higher risk of experiencing severe outcomes if they contract COVID-19. This risk of severe outcomes can be even greater if they have comorbid, underlying conditions. Furthermore, there is some evidence that COVID-19 can lead to the development of type 2 diabetes. Managing diabetes and keeping up with current vaccination recommendations can help mitigate the severity of the disease. Here, we review the role of community leadership and healthcare teams in engaging individuals with diabetes on the topic of COVID-19 vaccination.
COVID-19 and Obesity
Patients who are overweight or have obesity are more likely to develop severe COVID-19 infections than non-obese patients. Minority patients are at a higher risk of obesity and severe COVID-19. Preventing infection starts by encouraging your patients to receive an updated vaccine. In this video, Drs. Enrique Caballero and Fatima Cody Stanford discuss why COVID-19 disproportionately affects patients who are overweight or have obesity, and how to prevent severe disease.
The Importance of Protecting Chronic Disease Patients against COVID-19
This video focuses on the importance of protecting patients with chronic diseases from COVID-19, discussing how comorbidities like diabetes, obesity, and chronic kidney disease increase the risk of severe outcomes. Experts emphasize the concept of “comorbidity stacking” and the need for enhanced vaccine uptake in these vulnerable populations, using data from the dashboard to illustrate the significant impact of these conditions on hospitalization and mortality rates
Chronic Diseases
COVID-19 and Chronic Lung Disease
This short video provides an overview of the relationship between COVID-19 and chronic lung disease, including explaining why individuals with this disease are at a heightened risk of COVID-19 infection and hospitalization. The video addresses specific factors contributing to this higher risk, such as higher infection rates, additional immunosuppressive medications and how those with chronic lung disease have been impacted by the ongoing pandemic. Additionally, it delves into COVID-19 prevention and treatment options for individuals with CKD, by offering valuable insights to support HCPs’ understanding of chronic lung disease in navigating the challenges posed by COVID-19.
High-Risk Adult Populations
Promoting COVID-19 Vaccine Confidence Among Physician Assistants
Expert discussion on the importance of COVID-19 vaccinations for physician assistants (PAs), including reasons for vaccine resistance and ways to encourage PAs to increase COVID-19 vaccine uptake. Highlights of the discussion focus on the benefits of COVID-19 vaccines and the protection they may provide to PAs and the public. The vast research into mRNA technology is touched on which helped to develop the mRNA COVID-19 vaccine technology at record speed and the importance PAs play in building vaccine confidence in the community is discussed with the goal of increasing COVID-19 vaccine uptake and protecting health workers and the community.
High-Risk Adult Populations
Promoting COVID-19 Vaccine Confidence Among Physician Assistants
Expert discussion on the importance of COVID-19 vaccinations for physician assistants (PAs), including reasons for vaccine resistance and ways to encourage PAs to increase COVID-19 vaccine uptake. Highlights of the discussion focus on the benefits of COVID-19 vaccines and the protection they may provide to PAs and the public. The vast research into mRNA technology is touched on which helped to develop the mRNA COVID-19 vaccine technology at record speed and the importance PAs play in building vaccine confidence in the community is discussed with the goal of increasing COVID-19 vaccine uptake and protecting health workers and the community.
Impact of COVID-19 on Employee Health
As organizations strive to maintain productivity and profitability while transitioning back to in-person work, understanding the importance of employee health becomes paramount. This webinar explores the crucial topic of employee health and its relation to COVID-19. Experts discuss the economic impact of absenteeism and presenteeism, and describe the significance of vaccination in safeguarding employees from illness and fostering a healthier work environment.
Setting the Stage on COVID-19 in Fall and Winter 2023: COVID-19 and High Risk Patients
Learn more about which of your patients are at higher risk of severe COVID-19
The Value of Community Resources to Help with Immunization in African American Communities
COVID-19 has disproportionately affected African American individuals in the United States. It has led to higher case rates, more deaths, and more severe
economic effects in Black and African American communities than in other racial and
ethnic communities. In this series, experts discuss challenges with vaccination in
African American and recent immigrant populations, as well as practical steps to
promote immunization in these groups. They will address key challenges with access, common mistakes that HCPs make, and provide examples on how to address these communities.
In this video, experts discuss resources that can help with immunization in the African American community. They review the significant role of community leaders and faith leaders and provide examples of how they can help encourage COVID-19 vaccination within their community.
Marginalized Communities: COVID-19 and the Latinx Population
The Hispanic community has been significantly affected by the COVID-19 pandemic. In this video, experts discuss factors that may contribute to the high impact of COVID-19 in this population, review the most current CDC recommendations for COVID-19 vaccination, and provide best practices for encouraging vaccine uptake.
Spreading COVID-19 Vaccine Confidence Among Nurse Practitioners
Expert discussion on the importance of COVID-19 vaccinations for nurse practitioners (NPs), including reasons for vaccine resistance and ways to encourage NPs to increase COVID-19 vaccine uptake. Highlights of the discussion focus on the science supporting the safety and efficacy of COVID-19 vaccines and the protection they provide to health care providers and the public. The importance NPs play in building vaccine confidence among health workers and the community is discussed with the aim of increasing uptake and protecting all involved.
Marginalized Communities: COVID-19 in the Black Community
COVID-19 has significantly affected the Black community. In this video, experts discuss factors that may have contributed to the disproportionate impact of COVID-19 on Black Americans, the diversity seen in clinical trials, CDC recommendations, and best practices to increase confidence in the uptake of the updated COVID-19 vaccines.
Populations at Risk: COVID-19 and Communities for whom English is a Second Language
In this video, experts review the impact of COVID-19 on individuals for whom English as a Second Language (ESL). They examine the significant burden of language disparities, provide effective strategies for clinicians to improve vaccine uptake among ESL communities, and delve into the latest CDC recommendations to help ensure that patients stay up to date with COVID-19 vaccines.
Challenges to COVID-19 Vaccination in Black Americans
Low levels of COVID-19 vaccine uptake among Black Americans remain a significant concern. In this video, experts discuss the factors that may contribute low vaccine uptake within the Black community, strategies for addressing patient concerns, and best practices to increase confidence in COVID-19 vaccine uptake. Search terms: COVID-19 challenges, African Americans, Black Americans, vaccine uptake, CDC recommendations, communicating with patients
Marginalized Communities: COVID-19 and Rural Communities
COVID-19 has significantly affected individuals living in rural communities. In this video, experts discuss vaccination rates in this population, factors that contribute to lower vaccine uptake, and strategies for improving healthcare access and vaccine uptake in rural communities.
Successful Initiatives: Boosting COVID-19 Vaccination in the Latino Community
In this video, experts discuss initiatives across the United States that helped overcome vaccination barriers and that helped increase COVID-19 vaccine uptake in the Latino community. They describe the importance of these initiatives and provide real-life examples of strategies that have yielded positive outcomes.
COVID-19: Success Stories in the Black Community
This program showcases a collection of successful initiatives across the United States that addressed barriers to vaccination in Black communities. These success stories exemplify the power of collaborative efforts in overcoming vaccine hesitancy and increasing vaccine uptake. By sharing these inspiring narratives, the program empowers clinicians with best practices and evidence-based approaches to foster trust, educate, and engage with Black populations.
Impact of COVID-19 on Latino Communities
COVID-19 has had a significant impact on the Latino population in the United States. In this webinar, experts describe the burden of COVID-19 in Latinos, current data on vaccine uptake, and strategies to encourage staying up to date with COVID-19 vaccination in this population.
Populations at Risk Series: Impact of COVID-19 on Latino Communities (Spanish version)
This webinar explores the impact of COVID-19 on the Latino and Hispanic communities in the United States. The speakers discuss specific and interrelated barriers to vaccination among Latino populations, including social, cultural and economic aspects; predisposing risk factors, and health inequities, technological and language challenges, vaccine hesitancy, and immigration status. The speakers also suggest strategies for healthcare providers to help their patients stay current with their COVID-19 vaccinations.
Vaccine Uptake and Effectiveness in Immunocompromised Patients
This video discusses the challenges of COVID-19 vaccination among immunocompromised patients, focusing on the low uptake of mRNA vaccines and the need for updated doses. It presents data showing reduced vaccine effectiveness in these patients, stressing the importance of receiving the latest vaccine, including the one targeting the XBB.1.5 variant. The video underscores the need for ongoing immunization efforts to adapt to changing virus strains and protect this vulnerable population.
COVID-19 and LGBTQIA2+ Communities
Lesbian, gay, bisexual, and transgender (LGBTQ+) populations have a higher prevalence of health conditions associated with severe COVID-19 illness as compared to non-LGBT populations. This group also experiences higher rates of barriers to care, stigma, and jobs in industries affected by increased exposure of economic sensitivity to the COVID-19 pandemic. Here, we discuss the impact of COVID-19 on this community, including higher levels of risk, barriers to care, likelihood of following public health measures, mental health impact, and vaccine perspectives.
The Burden of COVID-19 on Immunocompromised Patients
This video outlines the burden of COVID-19 on immunocompromised patients, emphasizing their higher risk of severe outcomes and hospitalizations. It discusses the CDC’s recommendations for protecting this vulnerable population, including vaccination, avoidance of crowded spaces, and appropriate use of COVID therapeutics. The video also highlights the importance of healthcare provider guidance, especially for patients on immunosuppressants or those with complex medication regimens.
COVID-19 and Vaccine Considerations for Veterans & the Troops
Veterans are at a higher risk of severe complications from COVID-19 than the general population, due to age and comorbidities. COVID-19 can also sideline young on-duty military members and spread through army units. US Army pharmacist and vaccine specialist John Gräbenstein talks about the importance of COVID-19 vaccination in active service members and veterans, and how to motivate these patients to get an updated COVID-19 vaccine.
COVID-19 and Homeless Individuals
In this informative video, experts address the amplified risk factors for COVID-19 infection and poorer outcomes for people experiencing homelessness (PEH). They also highlight how comorbidities, accelerated aging, and ongoing mental health issues in PEH may heighten the severity of COVID-19 illness for these individuals. The physicians also discuss the challenges faced by healthcare and public health systems in trying to prevent or reduce the risks of COVID-19 infection in crowded shelters. Finally, they examine strategies for distributing COVID-19 vaccines to this vulnerable patient population and what are the Center for Disease Control and Prevention (CDC) recommendations for managing COVID-19 within homeless populations.
COVID-19 and Immunosuppression Therapy
In this video experts discusses how people requiring immunosuppressive therapy (IST) may be at higher risk of severe COVID-19 outcomes, why COVID-19 vaccines in these populations may be less effective, and what the latest Center for Disease Control and Prevention (CDC)’s recommendations are regarding updated (2023–2024 Formula) mRNA COVID-19 vaccines for these patient populations needing IST.
Immunocompromised
Populations at Risk: COVID-19 and Immunocompromised People
Immunocompromised people may be more likely to be hospitalized with a COVID-19 infection. Immunocompromised people need more vaccines than the general population. Depending on their condition, timing COVID-19 vaccines before or after an immunosuppressing treatment may improve vaccine efficacy.
Populations at Risk: COVID-19 and Cancer
Increased age and impaired immunity drive your cancer patients’ risk of severe COVID-19 infection. We now know that COVID-19 vaccinations are safe and effective at preventing severe disease, especially in this at-risk population. In this video, Drs. Martin Mahoney and Jeffery Lancet review what factors raise the risk of COVID-19 infection in cancer patients and why they should be encouraged to receive an updated vaccine.
Populations at Risk Series: COVID-19 and Immunocompromised Populations
Immunocompromised patients are not only at higher risk of severe COVID-19 outcomes, but with a reduced response to COVID-19 vaccines. Experts recommend additional doses of COVID-19 vaccines and immunocompetent family members are up to date with current COVID-19 vaccine recommendations to reduce the risk of these outcomes in this population. In this webinar, experts in transplant ID and oncology share their insight on strategies that healthcare professionals can use to protect their immunocompromised patients.
COVID-19 in Solid Organ Transplant Recipients
In this video, infectious diseases and organ transplantation experts, Drs. Ingi Lee, Onyema Ogbaugu, and Dorry Segev, address COVID-19 and immunocompromised individuals, specifically those awaiting or having undergone solid organ transplantation (SOT). Despite the pandemic’s end declaration by the World Health Organization, the SARS-CoV-2 virus persists, driving ongoing infections, hospitalizations, and deaths due to recent variants. Drs. Lee, Ogbaugu, and Segev discuss the continuing severe COVID-19 risks for SOT recipients, highlighting the importance of constant vigilance and safety measures for these vulnerable populations, and stressing the need for CDC-recommended updated (2023–2024 Formula) mRNA COVID-19 vaccines for SOT recipients and their caregivers.
COVID-19 and Hematopoietic Stem Cell Transplants
In this informative video, infectious disease experts Drs. Mayur Ramesh and William P. Dillon delve into the unique challenges faced by hematopoietic stem cell transplant (HSCT) recipients, who are at an elevate risk for severe COVID-19 outcomes due to their immunocompromised status. Combining extensive experience in infectious diseases with recommendations from the Center for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the National Institutes of Health (NIH), Dr. Ramesh and Dr. Dillon discuss the key risk factors that heighten the susceptibility of these medically complex individuals. They also examine the latest COVID-19 vaccines and shed light on recommendations and strategies to safeguard HSCT recipients.
Immunocompromised
Populations at Risk: COVID-19 and Immunocompromised People
Immunocompromised people may be more likely to be hospitalized with a COVID-19 infection. Immunocompromised people need more vaccines than the general population. Depending on their condition, timing COVID-19 vaccines before or after an immunosuppressing treatment may improve vaccine efficacy.
Long COVID
Best Practices Vaccine Hesitancy in Kids and Parents
Primary care physicians and pharmacists have been frontline healthcare providers during the COVID-19 pandemic, delivering immunizations and information about COVID-19 vaccines to their patients. In this series, experts discuss vaccine uptake and provide their best practices for addressing vaccine hesitancy in both adult and pediatric populations. They will address key questions that you and your patients may have regarding vaccine efficacy and safety, bivalent boosters, and common myths about COVID-19.
In this video, experts describe common factors behind parental vaccine hesitancy and provide best practices for effectively communicating the risks of vaccination versus the risks of COVID-19 to concerned parents.
Long COVID
Best Practices Vaccine Hesitancy in Adults
Primary care physicians and pharmacists have been frontline healthcare providers during the COVID-19 pandemic, delivering immunizations and information about COVID-19 vaccines to their patients. In this series, experts discuss vaccine uptake and provide their best practices for addressing vaccine hesitancy in both adult and pediatric populations. They will address key questions that you and your patients may have regarding vaccine efficacy and safety, bivalent boosters, and common myths about COVID-19.
In this video, experts describe the best practices that healthcare providers can adopt to address vaccine hesitancy in adults.
Best Practices Vaccine Hesitancy in Kids and Parents
Primary care physicians and pharmacists have been frontline healthcare providers during the COVID-19 pandemic, delivering immunizations and information about COVID-19 vaccines to their patients. In this series, experts discuss vaccine uptake and provide their best practices for addressing vaccine hesitancy in both adult and pediatric populations. They will address key questions that you and your patients may have regarding vaccine efficacy and safety, bivalent boosters, and common myths about COVID-19.
In this video, experts describe common factors behind parental vaccine hesitancy and provide best practices for effectively communicating the risks of vaccination versus the risks of COVID-19 to concerned parents.
Best Practices Vaccine Refusers
Primary care physicians and pharmacists have been frontline healthcare providers during the COVID-19 pandemic, delivering immunizations and information about COVID-19 vaccines to their patients. In this series, experts discuss vaccine uptake and provide their best practices for addressing vaccine hesitancy in both adult and pediatric populations. They will address key questions that you and your patients may have regarding vaccine efficacy and safety, bivalent boosters, and common myths about COVID-19.
In this video, experts discuss best practices for healthcare practitioners when communicating with a vaccine refuser.
Long COVID in Children – What You Need To Know About This Challenging Complication
Post Acute COVID Syndrome (PACS) or long COVID is a common complication associated with COVID infections. Even patients with mild initial symptoms from COVID-19, have had prolonged symptoms for weeks to months after the acute infection. Children and adolescents are also at risk of these conditions. In this video, experts discuss the clinical presentation, prevalence and potential impact of long COVID on children.
Setting the Stage on COVID-19 in Fall and Winter 2023: COVID Fatigue and Low Vaccine Uptake
Many patients believe that COVID-19 is over and they no longer need to receive any future vaccine doses. Learn more about addressing COVID fatigue and increasing vaccine uptake.
Best Practices Vaccine Hesitancy in Adults
Primary care physicians and pharmacists have been frontline healthcare providers during the COVID-19 pandemic, delivering immunizations and information about COVID-19 vaccines to their patients. In this series, experts discuss vaccine uptake and provide their best practices for addressing vaccine hesitancy in both adult and pediatric populations. They will address key questions that you and your patients may have regarding vaccine efficacy and safety, bivalent boosters, and common myths about COVID-19.
In this video, experts describe the best practices that healthcare providers can adopt to address vaccine hesitancy in adults.
Older Adult
Populations at Risk: COVID-19 and Older Adults
The COVID-19 pandemic has severely impacted older adults in the United States. In this video, experts shed light on the profound impact of COVID-19 on older adults, exploring the unique challenges faced by this vulnerable population. They delve into the effectiveness of COVID-19 vaccines in this population and highlight how vaccination can help prevent severe illness, hospitalization, and death. This program aims to provide healthcare providers with the most up-to-date recommendations to help ensure the well-being of the elderly population in the face of COVID-19.
COVID-19 in Long Term Care Homes
Older adults in long-term care have been a disproportionately at-risk population since the COVID-19 pandemic began. This vulnerability is attributed to several compounding factors. Firstly, older adults are known to be the highest-risk age group when it comes to experiencing the burden of COVID-19 disease. Secondly, the specific living conditions in long-term care facilities can further put residents at an elevated risk of infection. Staff and visitors pose threats to residents by bringing COVID-19 into facilities and exposing residents. Implementing certain protective measures and adhering to current vaccination recommendations can effectively mitigate the severity of the disease. Getting updated vaccinations is recommended for staff, visitors, and residents of long-term care facilities. Here, we review the role of COVID-19 vaccination in risk mitigation for older adults in long-term care.
COVID-19 and Dementia
Patients with dementia are often older adults with comorbid conditions that increase their risk of severe COVID-19, hospitalization, and death. They also represent a unique population with cognitive impairment, complicating safety measures often followed to prevent COVID-19. In this video, Drs. Stefan Gravenstein and Richard W. Besdine discuss the factors driving the increased risk of severe COVID-19 in patients with dementia, the long-term effects of infection, and how vaccination may help mitigate severe disease.
COVID-19 in Long Term Care
The video covers the elevated risks and challenges of managing COVID-19 in long-term care facilities. Experts discuss how factors like high-density living, increased caregiving needs, and pre-existing comorbidities like dementia and hypertension significantly raise the risk of severe outcomes and mortality among residents.
Comorbidities and COVID-19 infection in Older Adults
This video highlights the increased risk of severe COVID-19 outcomes in older adults with comorbidities. Experts discuss how conditions like cardiovascular disease, arising either pre-existing or as a consequence of COVID-19, contribute to heightened risks. Emphasis is placed on the importance of reducing these risks through measures like vaccination and public health practices.
2023 ACIP Recommendations
This video outlines the 2023/2024 COVID-19 vaccination recommendations, particularly focusing on the bivalent mRNA vaccines and their efficacy against circulating SARS-CoV-2 variants, including XBB sub-lineage. It highlights the importance of vaccinating all individuals aged six months and older, with specific emphasis on the heightened risk and mortality in different age groups, including older adults.
Setting the Stage on COVID-19 in Older Adults
This video features discussions on the significant impact of COVID-19 on older adults, emphasizing the increased risk of hospitalizations and mortality in this age group. Utilizing data from dashboard representing over 38 million Americans, the speakers highlight the ongoing burden of the disease, especially in 2023, and the importance of continued vigilance and vaccine boosting for older patients.
Older Adult
Populations at Risk: COVID-19 and Older Adults
The COVID-19 pandemic has severely impacted older adults in the United States. In this video, experts shed light on the profound impact of COVID-19 on older adults, exploring the unique challenges faced by this vulnerable population. They delve into the effectiveness of COVID-19 vaccines in this population and highlight how vaccination can help prevent severe illness, hospitalization, and death. This program aims to provide healthcare providers with the most up-to-date recommendations to help ensure the well-being of the elderly population in the face of COVID-19.
Pediatric
Ask, Recommend and Protect – Three simple steps to ensuring your pediatric patients are protected when returning to school
Routine pediatric immunizations have decreased dramatically when compared to pre-pandemic levels. Well-child visits are a crucial time for ensuring your youngest patients have received all routine immunizations including influenza and COVID-19. In this video, Drs. Wendy Wright and Jessica Peck review the impact of the COVID- 19 pandemic on pediatric vaccine uptake and practical recommendations that healthcare professionals can utilize to increase vaccine uptake in their practice.
Pediatric
Ask, Recommend and Protect – Three simple steps to ensuring your pediatric patients are protected when returning to school
Routine pediatric immunizations have decreased dramatically when compared to pre-pandemic levels. Well-child visits are a crucial time for ensuring your youngest patients have received all routine immunizations including influenza and COVID-19. In this video, Drs. Wendy Wright and Jessica Peck review the impact of the COVID- 19 pandemic on pediatric vaccine uptake and practical recommendations that healthcare professionals can utilize to increase vaccine uptake in their practice.
COVID-19 and Pregnancy: The Risk and Benefit to Vaccination
Pregnant and recently pregnant individuals are at an increased risk of severe COVID-19 and subsequent fetal complications. Recent data demonstrate that COVID-19 vaccinations are safe and effective at preventing severe disease in this subset of patients. In this video, Drs. Jessica Peck and Kevin Ault review the factors contributing to pregnant and recently pregnant individuals’ risks, and how vaccinations improve birthing outcomes.
Pregnant and recently pregnant people may be at higher risk of severe illness from COVID-19. COVID-19 infection may also increase the risk of pregnancy complications that affect the health of the mothers and developing babies.
Raising Vaccine Confidence
VRBPAC and ACIP Outlook: Understanding the Update to COVID-19 Vaccines for Fall
On June 15th, 2023, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to evaluate the current data regarding the COVID-19 pandemic, vaccine effectiveness and evidence supporting potential future vaccine candidates. This webinar summarizes the key information shared within the meeting and highlight for healthcare professionals the potential change to the COVID-19 vaccine strategy in the fall. The experts also highlight how healthcare professionals can integrate this information into discussions with patients in their practice.
Navigating COVID-19 Vaccine Updates: Recommendations from VRBPAC and ACIP
In this video, experts discuss the latest updates and recommendations from the Vaccines and Related Biological Products Advisory Committee (VRBPAC) and the Advisory Committee on Immunization Practices (ACIP)
Preparing for a Successful Fall: Understanding VRBPAC and ACIP Recommendations for COVID-19 Vaccines
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) and the Advisory Committee on Immunization Practices (ACIP) recently provided their updated recommendations regarding COVID-19 vaccines. In this video, experts discuss these recommendations and review how clinicians can prepare for a successful fall immunization season.
Updated COVID-19 vaccines in patients at the highest risk of morbidity and mortality
Pharmacists play an integral role in providing care for the general population, especially those with chronic health issues. Here, we discuss the role of pharmacists in educating patients at highest risk of morbidity and mortality following COVID-19 infection, and what can be done to increase vaccine confidence in this population. Severe outcomes can include increased risk of hospitalization, admission to the ICU, need for ventilation or intubation, and increased likelihood of mortality following COVID-19 infection. It’s important to educate and protect this patient group by informing them of their increased risk factors and how to best manage them, including updated vaccination.
Updated COVID-19 vaccines: dispelling myths and how to deliver a presumptive recommendation
Pharmacists play an integral role in providing care for the general population, especially in the education and administration of vaccines. Experts discuss the latest recommendations from advisory committees around COVID-19 vaccination, including recent changes to COVID-19 vaccines and strategies, as well as actions that pharmacists can take to encourage updated vaccines in their patients.
Setting the Stage on COVID-19 in Fall and Winter 2023
Learn more of what to expect from COVID-19 during the fall and winter of 2023.
Setting the Stage on COVID-19 in Fall and Winter 2023: New ACIP Recommendations
Learn more about the ACIP COVID-19 recommendations for the 2023-2024 season.
Setting the Stage on COVID-19 in Fall and Winter 2023: Misinformation and the value of Presumptive Offering
Learn about some strategies to address vaccine misinformation with your patients.
Setting the Stage on COVID-19 in Fall and Winter 2023: Educational Tools & Resources for Providers
Learn more about the COVID tools and resources to help to improve communication with your patients
What's next for COVID-19 real world evidence? The future of fighting the pandemic
Pharmacists play an integral role in providing care for the general population, especially in the education and administration of vaccines. Here, we discuss real-world evidence, how it produces important data for informing vaccine recommendations, and how it can be used as a resource to address vaccine hesitancy in patients.
mRNA vaccines were shown to help protect people across a diverse range of races and ethnicities.
Raising Vaccine Confidence
VRBPAC and ACIP Outlook: Understanding the Update to COVID-19 Vaccines for Fall
On June 15th, 2023, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to evaluate the current data regarding the COVID-19 pandemic, vaccine effectiveness and evidence supporting potential future vaccine candidates. This webinar summarizes the key information shared within the meeting and highlight for healthcare professionals the potential change to the COVID-19 vaccine strategy in the fall. The experts also highlight how healthcare professionals can integrate this information into discussions with patients in their practice.
Respiratory Diseases
Populations at Risk: COVID-19 and Asthma
For patients with underlying asthma, COVID-19 infection can lead to more severe outcomes. These outcomes can include increased risk for hospitalization, intensive care unit admission, readmission, and ventilation, especially for those with severe or uncontrolled asthma or comorbid chronic heart disease. It’s important to educate and protect this patient group by informing them of their increased risk factors and how to best manage them, including recommending vaccination and adhering to public health recommendations. Maintaining optimal asthma control is a critical aspect to ensure patient health through providing written asthma action plans, and escalating treatment according to guidelines.
Respiratory Diseases
Populations at Risk: COVID-19 and Asthma
For patients with underlying asthma, COVID-19 infection can lead to more severe outcomes. These outcomes can include increased risk for hospitalization, intensive care unit admission, readmission, and ventilation, especially for those with severe or uncontrolled asthma or comorbid chronic heart disease. It’s important to educate and protect this patient group by informing them of their increased risk factors and how to best manage them, including recommending vaccination and adhering to public health recommendations. Maintaining optimal asthma control is a critical aspect to ensure patient health through providing written asthma action plans, and escalating treatment according to guidelines.
Populations at Risk: COVID-19 and Respiratory Disease
People with respiratory conditions are highly diverse both in age and severity. Some patients with respiratory conditions are at much higher risk of severe outcomes from COVID-19. In this webinar, experts will review the latest research on the impact of COVID-19 on people with COPD, asthma, and other respiratory conditions. They will also provide key insight on what healthcare professionals can implement in practice to reduce the impact of COVID-19 in this patient population.
Strategies to Increase Vaccine Uptake in Respiratory Conditions Populations
The video reviews how healthcare professionals can increase COVID-19 vaccine uptake in patients with respiratory conditions. They explore strategies to engage patients, the importance of healthcare provider recommendations, and the need for immediate immunization to protect vulnerable populations.
Importance of Respiratory Conditions and COVID-19 Concerns
This video discusses the impact of COVID-19 on individuals with respiratory conditions such as asthma and COPD. It highlights the risks these patients face and the importance of COVID-19 vaccination, providing insights from health experts and emphasizing updated guidelines for healthcare professionals.
Vaccination Uptake and Respiratory Conditions Populations
This video focuses on increasing COVID-19 vaccine uptake in patients with respiratory conditions. It covers strategies for healthcare providers to encourage vaccination, the importance of staying updated with vaccinations, and the current ACIP recommendations for COVID-19 immunization in people with respiratory conditions.
